Latest News and Press Releases
Want to stay updated on the latest news?
-
KUALA LUMPUR, MALAYSIA, May 06, 2025 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; “Cyclacel” or the “Company”) today announced that it entered into an Exchange...
-
San Diego, CA, April 10, 2025 (GLOBE NEWSWIRE) -- HUMBL, Inc. (OTC: HMBL), a U.S.-based holding company with a focus on technology, today announced the mutual unwinding of its previously announced...
-
San Diego, CA, Feb. 28, 2025 (GLOBE NEWSWIRE) -- HUMBL, Inc. (OTC: HMBL) announced the execution of a $2,000,000 Equity Swap Agreement and strategic partnership with NUBURU, Inc. (NYSE: BURU)...
-
Company Takes Steps to Uplist to NASDAQ or a National Exchange PARSIPPANY, New Jersey, June 27, 2024 (GLOBE NEWSWIRE) -- Global Technologies, Ltd. (OTC Pink: GTLL) (the “Company”), is...
-
The Company will Acquire Back 10% of Issued and Outstanding Shares of its Non-Wholly Owned Subsidiary and Manufacturing Division POMPANO BEACH, FLORIDA., Feb. 14, 2023 (GLOBE NEWSWIRE) -- BioStem...
-
Cheyenne, Wyoming, Dec. 12, 2022 (GLOBE NEWSWIRE) -- Protect Pharmaceutical Corporation, Inc. (OTC:PRTT) informs, that the Share Exchange Agreement №1, signed on June 15, 2022 was not executed due...
-
New York, NY, Sept. 14, 2022 (GLOBE NEWSWIRE) -- Global Tech Industries Group, Inc. (OTCQB: GTII) (“GTII” or the “Company”), www.gtii-us.com, a Nevada corporation, announced today that it has...
-
After many months of strategic planning and development, the two companies are ready to announce the details of their upcoming acquisition deal. Minsk, Belarus., June 23, 2022 (GLOBE NEWSWIRE) --...
-
ST. PETERSBURG, Fla., March 11, 2022 (GLOBE NEWSWIRE) -- Global Technologies, Ltd (OTC Pink: GTLL) (the “Company”), a holding corporation, which, through its subsidiaries, has operations engaged in...
-
Chadds Ford, PA, July 01, 2021 (GLOBE NEWSWIRE) -- Qualis Innovation Inc. (“Qualis”) completed a share exchange agreement with mPathix Health Inc.(“mPathix”) through which mPathix will become a...